Main content
Update: Confusion around AstraZeneca vaccine data
Questions arise over efficacy levels
On Monday, the world heard how the UK's Covid vaccine - from AstraZeneca and Oxford University - was highly effective in advanced trials. But on Thursday, multiple news outlets in the UK and US reported that there were questions over the data. The FT’s Donato Paolo Mancini explains the concerns. Also in the programme, the price of the digital currency Bitcoin slumped today after rallying through the year. Billy Bambrough, who writes about Bitcoin and other cryptocurrencies for Forbes, explains why the currency can be so volatile.
Podcast
-
World Business Report
The latest business and finance news from around the world, on the Βι¶ΉΤΌΕΔ